High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.
about
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesHow I treat HIV-associated lymphomaCentral nervous system prophylaxis in diffuse large B-cell lymphoma.Primary leptomeningeal lymphoma: International Primary CNS Lymphoma Collaborative Group report.A systematic approach to the diagnosis of suspected central nervous system lymphoma.How to facilitate early diagnosis of CNS involvement in malignant lymphoma.Primary intraocular lymphoma: diagnosis and differential diagnosis.Central nervous system disease in hematologic malignancies: historical perspective and practical applications.Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.Detection of cancer cells in the cerebrospinal fluid: current methods and future directions.Burkitt's Lymphoma and B-Cell Lymphoma Unclassifiable With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt's Lymphoma in Patients With HIV: Outcomes in a South African Public HospitalCurrent strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohortMy treatment approach to patients with diffuse large B-cell lymphoma.Leptomeningeal involvement in B-cell chronic lymphocytic leukemia: a case report and review of the literature.Use of TransFix™ cerebrospinal fluid storage tubes prevents cellular loss and enhances flow cytometric detection of malignant hematological cells after 18 hours of storage.Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse.Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma GroupAntithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis.AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.Leptomeningeal metastases: a RANO proposal for response criteria.Central nervous system-directed preventative therapy in adults with lymphoma.Leptomeningeal Metastasis: Challenges in Diagnosis and TreatmentInternational Central Nervous System and Ocular Lymphoma Workshop: recommendations for the futureNeoplastic meningitis from solid tumors: a prospective clinical study in lombardia and a literature review on therapeutic approaches.Acute kidney injury and inflammatory immune reconstitution syndrome in mixed genotype (A/E) hepatitis B virus co-infection in HIV-associated lymphomaUsefulness of Flow Cytometric Analysis for Detecting Leptomeningeal Diseases in Non-Hodgkin LymphomaPineal Diffuse Large B-Cell Lymphoma Concomitant With Pituitary Prolactinoma: Possible Correlation Between 2 Distinguished Pathologies: A Case Report.Flow cytometry increases the sensitivity of detection of leukemia and lymphoma cells in bronchoalveolar lavage specimensCentral nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trialMolecular genetic analysis of haematological malignancies II: Mature lymphoid neoplasms.Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group.Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapyCentral nervous system involvement in AIDS-related lymphomasPrediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography.Primary intraocular lymphoma.Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).Known and emerging biomarkers of leptomeningeal metastasis and its response to treatment.
P2860
Q24604581-273FAABB-7164-4194-A4CA-1F3511562733Q26821860-506BC012-2415-4C3B-9E13-809AB6263393Q30251550-D8AE262D-460D-4114-A4C1-ACB438DA878DQ30409639-08C80F2B-DACC-449A-ADF6-D3090C09991AQ30586022-782A983D-02C9-44A4-8A22-C0D0909A96BAQ31133442-1CBA6456-5671-47E6-A2AA-BFB3A46AA6DBQ33479622-B14134F3-7DF4-48EB-BD61-9214A1B9CF8AQ33585849-DEF27317-4BAB-4051-AFE7-779FA2F9799CQ33828585-F224A26B-4D6A-4B84-9FB4-6839E072CAC7Q33836335-9E66B2C2-FA13-46C2-986D-D5091D8F899EQ33859497-8586A77E-19C4-457B-BBD1-1ACFD0CC60EBQ34072931-332F2E80-2D59-4B44-A893-38BA078682CCQ34132849-406DA14D-D8A4-4A44-9A5E-026ED2827503Q34251964-B5509A48-4E98-4FCE-8A33-8117BD0BDBA5Q34581853-0B5A4675-90B9-4653-81A7-8781BDF54F08Q34722394-9A5EF003-EA1C-4270-82CA-2959120D7830Q35082516-CE7C46DB-7EA3-468A-951F-68AB15A745B3Q35236072-B6E2F102-11C1-428C-8847-7B67DAF67D13Q35607611-C452F647-20D4-4363-8240-8F68679AC7E2Q35633814-4301D523-1680-4D37-B297-4493769EAF03Q35836856-8C73A1B6-991C-4E4E-91B2-C1B562FD2223Q36236770-348339A8-05EC-4135-857E-01CC29778C5FQ36262219-36E12F33-3235-42AF-8294-1E53D025D144Q36469191-9CEE059A-02F7-46FF-B30C-3882E2276F7BQ36530118-0B8EFBA1-0A71-4655-BD31-2CDBD57B45B5Q36582736-0A3DBB87-B886-480B-89D7-9A333D46F56AQ36584311-91FB55CA-1C77-44A4-9D2B-DA9A74B3C4A6Q36636678-A0A8E30D-C1A4-4853-96B5-5E2DE1DF139EQ36653701-25398DA6-D52D-4B72-A751-3023BDB05E8EQ36687628-F4786E9D-484D-48EA-B797-07FCE548FE92Q36859222-C994AFAB-78A6-4ECF-8220-14FBA775E758Q36872779-AA56E1A1-7802-4A92-BC5B-C333DD96EED8Q36934293-3AB5AED4-5F6C-4405-B9B2-D9287FB3C69BQ36962906-BF331EDB-89B2-4F01-AD79-0D0F6CD26C3EQ36989459-C2AC72D3-FCC7-4349-A79D-04BF7325E94DQ37026232-3FB0188F-4687-4BFC-A321-DFB85C176897Q37321316-07F35170-02C5-4AB5-AD06-C9A93589C94AQ37418812-B1D1F1DA-0EF5-4CBA-8EAD-38865A0F757CQ37618814-CF13DDD9-648B-4932-BD22-0D701EC60EC5Q37690311-592768B4-E699-4C4A-ACC7-86B9202627B2
P2860
High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
High incidence of occult lepto ...... low cytometry versus cytology.
@en
High incidence of occult lepto ...... low cytometry versus cytology.
@nl
type
label
High incidence of occult lepto ...... low cytometry versus cytology.
@en
High incidence of occult lepto ...... low cytometry versus cytology.
@nl
prefLabel
High incidence of occult lepto ...... low cytometry versus cytology.
@en
High incidence of occult lepto ...... low cytometry versus cytology.
@nl
P2093
P1433
P1476
High incidence of occult lepto ...... low cytometry versus cytology.
@en
P2093
Andrea Abati
Armando Filie
Elaine S Jaffe
John E Janik
Kieron Dunleavy
Maryalice Stetler-Stevenson
Nicole Grant
Richard F Little
Seth M Steinberg
Upendra Hegde
P304
P356
10.1182/BLOOD-2004-05-1982
P407
P577
2004-09-09T00:00:00Z